AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery

Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targetsGene Editing: Using CRISPR and CAR-T engineering for precision therapiesAI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generationAutomation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)Clinical Acceleration: AI-powered patient matching for faster trialsRoadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readinessTune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.